Back to News
Market Impact: 0.25

HSTM or SHOP: Which Is the Better Value Stock Right Now?

HSTMSHOPNDAQ
Company FundamentalsAnalyst EstimatesAnalyst InsightsCorporate EarningsInvestor Sentiment & Positioning
HSTM or SHOP: Which Is the Better Value Stock Right Now?

Zacks compares HealthStream (HSTM) and Shopify (SHOP) from a value-investor perspective and finds HSTM the more attractive option: HSTM carries a Zacks Rank #2 (Buy) versus SHOP’s #3 (Hold) and earns a Value grade of B versus SHOP’s F, with materially lower forward P/E (34.93 vs. 110.41), lower PEG (2.91 vs. 4.47) and a much lower P/B (2.03 vs. 16.64). The Zacks Rank framework emphasizes earnings‑estimate revision trends, which Zacks says have improved more for HSTM, suggesting HSTM may offer better upside for value-focused portfolios relative to SHOP.

Analysis

Zacks' comparative note rates HealthStream (HSTM) as a Zacks Rank #2 (Buy) with a Value grade of B, versus Shopify (SHOP) at Rank #3 (Hold) with a Value grade of F. The piece cites materially different valuation metrics: HSTM’s forward P/E is 34.93, PEG 2.91 and P/B 2.03, while SHOP shows a forward P/E of 110.41, PEG 4.47 and P/B 16.64. These figures underpin Zacks’ view that earnings-estimate revisions have improved more meaningfully for HSTM than for SHOP. For value-focused investors the implication is that HSTM currently looks less richly priced relative to expected earnings revisions, whereas SHOP is trading with steep growth multiples that the Value grade flags as unfavorable. The note emphasizes Zacks’ framework—earnings-estimate revision trends drive the Zacks Rank—so short-term revision momentum favors HSTM. SHOP’s high P/E and P/B are consistent with a growth premium rather than value opportunity. Risks and limitations in the article include limited disclosure of revenue, margin or cash-flow figures and no forward growth rate specifics beyond PEGs; HSTM’s forward P/E of ~35 and PEG of 2.91 still reflect elevated expectations. Investors should therefore treat the comparison as a valuation signal to be confirmed by upcoming estimate revisions and company fundamentals rather than as a standalone buy recommendation.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.